Cytotoxic Effects of Jay Amin Hydroxamic Acid (JAHA), a Ferrocene-Based Class I Histone Deacetylase Inhibitor, on Triple-Negative MDA-MB231 Breast Cancer Cells

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Triple Negative ◽

Class I ◽

Cytotoxic Effects ◽

Histone deacetylase inhibitor suberoyl bis-hydroxamic acid suppresses cell proliferation and induces apoptosis in breast cancer cells

Molecular Medicine Reports ◽

10.3892/mmr.2014.3076 ◽

2014 ◽

Vol 11 (4) ◽

pp. 2908-2912 ◽

Cited By ~ 3

Author(s):

XINMIAO YANG ◽

NING ZHANG ◽

ZELIANG SHI ◽

ZHANGYU YANG ◽

XICHUN HU

Keyword(s):

Breast Cancer ◽

Cell Proliferation ◽

Cancer Cells ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Abstract 5847: A histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth with apoptosis in triple-negative breast cancer cells

10.1158/1538-7445.am2018-5847 ◽

2018 ◽

Author(s):

Hisako Ono ◽

Yoshihiro Sowa ◽

Yosuke Iizumi ◽

Mano Horinaka ◽

Tetsuya Taguchi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-14-0778 ◽

2015 ◽

Vol 14 (8) ◽

pp. 1848-1857 ◽

Cited By ~ 41

Author(s):

Amanda Schech ◽

Armina Kazi ◽

Stephen Yu ◽

Preeti Shah ◽

Gauri Sabnis

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Tumor Initiating Cells ◽

Inhibition of lymphangiogenic factor VEGF-C expression and production by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in breast cancer cells

Oncology Reports ◽

10.3892/or.2012.2188 ◽

2012 ◽

Vol 29 (3) ◽

pp. 1238-1244 ◽

Cited By ~ 6

Author(s):

HSUEH-TSEN CHENG ◽

WEN-CHUN HUNG

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Hydroxamic Acid ◽

Breast Cancer Cells ◽

Suberoylanilide Hydroxamic Acid ◽

Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells

Oncotarget ◽

10.18632/oncotarget.2154 ◽

2014 ◽

Vol 5 (14) ◽

pp. 5637-5650 ◽

Cited By ~ 84

Author(s):

Kyungsoo Ha ◽

Warren Fiskus ◽

Dong Soon Choi ◽

Srividya Bhaskara ◽

Leandro Cerchietti ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Parp Inhibitor ◽

Deacetylase Inhibitor ◽

Inhibitor Treatment

Histone deacetylase inhibitor 2-hexyl-4-pentynoic acid enhances hydroxyurea therapeutic effect in triple-negative breast cancer cells

Mutation Research/Genetic Toxicology and Environmental Mutagenesis ◽

10.1016/j.mrgentox.2021.503422 ◽

2021 ◽

pp. 503422

Author(s):

Chenxia Ding ◽

Benyu Su ◽

Qiaoling Li ◽

Wenwen Ding ◽

Guochao Liu ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Therapeutic Effect ◽

Breast Cancer Cells ◽

Triple Negative ◽

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

Breast Cancer Research ◽

10.1186/bcr3192 ◽

2012 ◽

Vol 14 (3) ◽

Cited By ~ 141

Author(s):

Chandra R Tate ◽

Lyndsay V Rhodes ◽

H Chris Segar ◽

Jennifer L Driver ◽

F Nell Pounder ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-4815-x ◽

2018 ◽

Vol 171 (1) ◽

pp. 43-52 ◽

Cited By ~ 6

Author(s):

Hisako Ono ◽

Yoshihiro Sowa ◽

Mano Horinaka ◽

Yosuke Iizumi ◽

Motoki Watanabe ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Mapk Pathway ◽

Abstract P6-14-01: A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in both HER2-overexpressing inflammatory and non-inflammatory breast cancer cells through FOXO3-mediated Bim1 expression

10.1158/1538-7445.sabcs14-p6-14-01 ◽

2015 ◽

Author(s):

Jangsoon Lee ◽

Chandra Bartholomeusz ◽

Gabriel N Hortobagyi ◽

Peter Ordentlich ◽

Naoto T Ueno

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Inflammatory Breast Cancer ◽

Breast Cancer Cells ◽

Class I ◽

Abstract PO-218: Molecular profiling of basal 2 subtypes of triple negative breast cancer cells and their response to a histone deacetylase inhibitor

10.1158/1538-7755.disp20-po-218 ◽

2020 ◽

Author(s):

Beverly Word ◽

Ebony Cotton ◽

George Hammons ◽

Beverly Lyn-Cook ◽

Density Stovall

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Breast Cancer Cells ◽

Triple Negative ◽

Molecular Profiling ◽